Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Growth (Status and Outlook) 2022-2028
- LP 4924929
- 88 Pages
- March 2022
- Medical Devices
The United States Gastroesophageal Reflux Disease (GERD) Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gastroesophageal Reflux Disease (GERD) Therapeutics market, reaching US$ million by the year 2028. As for the Europe Gastroesophageal Reflux Disease (GERD) Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Gastroesophageal Reflux Disease (GERD) Therapeutics players cover AstraZeneca, Eisai, GSK, and Takeda, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastroesophageal Reflux Disease (GERD) Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Antacids
Pro-kinetic agents
H2 Receptor Blockers
Proton Pump Inhibitors (PPIs)
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Heartburn
Acid reflux disorders
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
Eisai
GSK
Takeda
Johnson & Johnson
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2017-2028
2.1.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Segment by Type
2.2.1 Antacids
2.2.2 Pro-kinetic agents
2.2.3 H2 Receptor Blockers
2.2.4 Proton Pump Inhibitors (PPIs)
2.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
2.3.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Gastroesophageal Reflux Disease (GERD) Therapeutics Segment by Application
2.4.1 Heartburn
2.4.2 Acid reflux disorders
2.5 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application
2.5.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Application (2017-2022)
3 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Player
3.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Players
3.1.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Gastroesophageal Reflux Disease (GERD) Therapeutics by Regions
4.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth (2017-2022)
4.3 APAC Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth (2017-2022)
4.4 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022)
5.2 Americas Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2017-2022)
5.3 Americas Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2017-2022)
6.2 APAC Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2017-2022)
6.3 APAC Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics by Country (2017-2022)
7.2 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2017-2022)
7.3 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Gastroesophageal Reflux Disease (GERD) Therapeutics Forecast
10.1.3 APAC Gastroesophageal Reflux Disease (GERD) Therapeutics Forecast
10.1.4 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Forecast
10.1.5 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Forecast
10.2 Americas Gastroesophageal Reflux Disease (GERD) Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.2.2 Canada Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.2.3 Mexico Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.2.4 Brazil Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.3 APAC Gastroesophageal Reflux Disease (GERD) Therapeutics Forecast by Region (2023-2028)
10.3.1 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.3.2 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.3.3 Korea Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.3.4 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.3.5 India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.3.6 Australia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.4 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.4.2 France Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.4.3 UK Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.4.4 Italy Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.4.5 Russia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.5 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.5.2 South Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.5.3 Israel Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.5.4 Turkey Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.5.5 GCC Countries Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast
10.6 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecast by Type (2023-2028)
10.7 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Product Offered
11.1.3 AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 Eisai
11.2.1 Eisai Company Information
11.2.2 Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Product Offered
11.2.3 Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Eisai Main Business Overview
11.2.5 Eisai Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Product Offered
11.3.3 GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Takeda
11.4.1 Takeda Company Information
11.4.2 Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Product Offered
11.4.3 Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Takeda Main Business Overview
11.4.5 Takeda Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Product Offered
11.5.3 Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
12 Research Findings and Conclusion
Table 1. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Antacids
Table 3. Major Players of Pro-kinetic agents
Table 4. Major Players of H2 Receptor Blockers
Table 5. Major Players of Proton Pump Inhibitors (PPIs)
Table 6. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Type (2017-2022)
Table 9. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Application (2017-2022)
Table 12. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Player (2020-2022)
Table 14. Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players Head office and Products Offered
Table 15. Gastroesophageal Reflux Disease (GERD) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Regions (2017-2022)
Table 20. Americas Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Country (2017-2022)
Table 22. Americas Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Type (2017-2022)
Table 24. Americas Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Application (2017-2022)
Table 26. APAC Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Region (2017-2022)
Table 28. APAC Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Type (2017-2022)
Table 30. APAC Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Application (2017-2022)
Table 32. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Country (2017-2022)
Table 34. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Type (2017-2022)
Table 36. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Gastroesophageal Reflux Disease (GERD) Therapeutics
Table 45. Key Market Challenges & Risks of Gastroesophageal Reflux Disease (GERD) Therapeutics
Table 46. Key Industry Trends of Gastroesophageal Reflux Disease (GERD) Therapeutics
Table 47. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 53. AstraZeneca Details, Company Type, Gastroesophageal Reflux Disease (GERD) Therapeutics Area Served and Its Competitors
Table 54. AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Product Offered
Table 55. AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. AstraZeneca Main Business
Table 57. AstraZeneca Latest Developments
Table 58. Eisai Details, Company Type, Gastroesophageal Reflux Disease (GERD) Therapeutics Area Served and Its Competitors
Table 59. Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Product Offered
Table 60. Eisai Main Business
Table 61. Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Eisai Latest Developments
Table 63. GSK Details, Company Type, Gastroesophageal Reflux Disease (GERD) Therapeutics Area Served and Its Competitors
Table 64. GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Product Offered
Table 65. GSK Main Business
Table 66. GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. GSK Latest Developments
Table 68. Takeda Details, Company Type, Gastroesophageal Reflux Disease (GERD) Therapeutics Area Served and Its Competitors
Table 69. Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Product Offered
Table 70. Takeda Main Business
Table 71. Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Takeda Latest Developments
Table 73. Johnson & Johnson Details, Company Type, Gastroesophageal Reflux Disease (GERD) Therapeutics Area Served and Its Competitors
Table 74. Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Product Offered
Table 75. Johnson & Johnson Main Business
Table 76. Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Johnson & Johnson Latest Developments
List of Figures
Figure 1. Gastroesophageal Reflux Disease (GERD) Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Type in 2021
Figure 7. Gastroesophageal Reflux Disease (GERD) Therapeutics in Heartburn
Figure 8. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market: Heartburn (2017-2022) & ($ Millions)
Figure 9. Gastroesophageal Reflux Disease (GERD) Therapeutics in Acid reflux disorders
Figure 10. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market: Acid reflux disorders (2017-2022) & ($ Millions)
Figure 11. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Application in 2021
Figure 12. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Player in 2021
Figure 13. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 15. APAC Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 16. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Americas Gastroesophageal Reflux Disease (GERD) Therapeutics Value Market Share by Country in 2021
Figure 19. Americas Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption Market Share by Type in 2021
Figure 20. Americas Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Application in 2021
Figure 21. United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Region in 2021
Figure 26. APAC Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Application in 2021
Figure 27. China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Country in 2021
Figure 34. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Type in 2021
Figure 35. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Application in 2021
Figure 36. Germany Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Application in 2021
Figure 44. Egypt Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 50. APAC Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 51. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Canada Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. Korea Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Australia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. Germany Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. France Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. UK Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Italy Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. Russia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Spain Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Israel Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
